1002355-69-2

Basic information

• Product Name: tert-butyl 3-(4-bromophenyl)sulfanylazetidine-1-carboxylate
• Synonyms: tert-butyl 3-(4-bromophenyl)sulfanylazetidine-1-carboxylate
• CAS NO: 1002355-69-2
• Molecular Weight: 344.272
• Mol File: 1002355-69-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: tert-butyl 3-(4-bromophenyl)sulfanylazetidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 3-(4-bromophenyl)sulfanylazetidine-1-carboxylate(1002355-69-2)
• EPA Substance Registry System: tert-butyl 3-(4-bromophenyl)sulfanylazetidine-1-carboxylate(1002355-69-2)

Safety Data

• Hazardous Substances Data: 1002355-69-2(Hazardous Substances Data)

Usage

Uses

1-BOC-3-(4-bromophenyl)sulfanylazetidine is used as a reactant in the preparation of substituted azetidine derivatives as trace amine associated receptors (TAAR) ligands useful in the treatment of diseases.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1064194-10-0 3-bromo-azetidine-1-carboxylic acid tert-butyl ester 
• 106-53-6 para-bromobenzenethiol 

Downstream Products

• 887593-59-1 tert-butyl 3-((4-bromophenyl)sulfonyl)azetidine-1-carboxylate 

Relevant articles and documents

COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS

Disclosed are dihydroisoxazole compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein A, E, and R 1 are as defined herein. Also disclosed are compositions which comprise at least one of these dihydroisoxazole compounds, methods for inhibiting growth of mycobacterial cells as well as a method of treating mycobacterial infections by Mycobacterium tuberculosis comprising administering a therapeutically effective amount of these dihydroisoxazole compounds and/or a pharmaceutically acceptable salt thereof, or a composition comprising such compound and/or salt.

2-PYRIDONE COMPOUNDS

A 2-pyridone compound represented by the formula [1]: {wherein in the formula [1], the ring represented by A represents a benzene ring or a pyridine ring, X represents any of the structures represented by the formulas [3] shown below: V represents a single bond or a lower alkylene group, and W represents a single bond, an ether bond or a lower alkylene group (wherein the lower alkylene group may contain an ether bond)}, a tautomer or stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is a compound that has an excellent GK activating effect and is useful as a pharmaceutical.